Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Financing underway..

<< Previous

Bullboard Posts

Next >>

Post by chry200030on Jul 22, 2024 9:14pm

312 Views

Post# 36143626

Financing underway..

This is the first of many tranches coming.
When financing is done.... we move to step 2.
Once we're done, you'll be happy you bought down here... nuff said.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Theralase closes $775,000 first tranche of financing

2024-07-08 17:26 ET - News Release

Ms. Kristina Hachey reports

THERALASE(R) CLOSES $CAN 775,000 IN FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant